Capital Fund Management (CFM)
VRTX icon

Capital Fund Management (CFM)’s Vertex Pharmaceuticals VRTX Stock Holding History

Capital Fund Management (CFM)’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-17,500
Closed -$6.09M – 2312
2023
Q3 		$6.09M Buy
+17,500
New +$6.12M 0.02% 829
2023
Q1 		– Sell
-14,700
Closed -$4.25M – 1750
2022
Q4 		$4.25M Sell
14,700
-8,200
-36% -$2.5M 0.03% 668
2022
Q3 		$6.63M Buy
+22,900
New +$6.59M 0.05% 455
2020
Q2 		– Sell
-11,700
Closed -$2.78M – 1601
2020
Q1 		$2.78M Buy
11,700
+10,100
+631% +$2.32M 0.04% 442
2019
Q4 		$350K Buy
+1,600
New +$324K ﹤0.01% 1541
2018
Q1 		– Sell
-2,900
Closed -$435K – 2205
2017
Q4 		$435K Sell
2,900
-2,600
-47% -$385K ﹤0.01% 1509
2017
Q3 		$836K Buy
+5,500
New +$828K 0.01% 1029
2014
Q4 		– Sell
-4,500
Closed -$505K – 1824
2014
Q3 		$505K Buy
+4,500
New +$428K 0.01% 1150
2013
Q4 		– Sell
-3,000
Closed -$227K – 1858
2013
Q3 		$227K Sell
3,000
-44,800
-94% -$3.56M ﹤0.01% 1461
2013
Q2 		$3.82M Buy
+47,800
New +$3.52M 0.06% 431

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital Fund Management (CFM)'s VRTX Position: Q1 2026 in Review

Capital Fund Management (CFM) opened a new position in Vertex Pharmaceuticals (VRTX) in Q1 2026: 122,934 shares worth $54.9M. The stake represents 0.25% of the portfolio and ranks #63 among its holdings. This is a return to the name: Capital Fund Management (CFM) previously reported a position in VRTX as recently as Q1 2024.

Capital Fund Management (CFM) first reported a position in VRTX in Q2 2013 and has held it in 24 quarters since. 1,688 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Capital Fund Management (CFM) held 122,934 shares of Vertex Pharmaceuticals worth $54.9M as of Q1 2026.
  • Vertex Pharmaceuticals was a new Capital Fund Management (CFM) position in Q1 2026.
  • Vertex Pharmaceuticals made up 0.25% of Capital Fund Management (CFM)'s portfolio in Q1 2026, its #63 holding.
  • Capital Fund Management (CFM) first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 24 quarters since.
  • 1,688 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Capital Fund Management (CFM)'s 13F filing for Q1 2026, filed 14 May 2026.